ASLN

ASLAN Pharmaceuticals

ASLN • NASDAQ

ASLAN Pharmaceuticals is a publicly traded company trading on NASDAQ, led by CEO Carl Alan Jason Morton Firth EMBA,.

CEOCarl Alan Jason Morton Firth EMBA,
Employees27.0
Websiteaslanpharma.com

Next Earnings

Upcoming earnings announcement for ASLAN Pharmaceuticals

Date
Friday, April 10, 2026 (in 1 week)
Timing
Before Market Open (7:00 AM New York)
Fiscal Period
Q1 2025

Earnings History

Past 12 earnings reports for ASLAN Pharmaceuticals

DatePeriodEPSEPS SurpriseRevenueRev. SurpriseFiling
May 9, 2024Q1 2024
-$0.53Est: -$0.61
+13.1%
-
——
Apr 12, 2024Q4 2023
-$0.78Est: -$0.65
-20.0%
-
——
Oct 27, 2023Q3 2023
-$0.56Est: -$0.78
+28.2%
-
——
Aug 11, 2023Q2 2023
-$0.11Est: -$0.87
+87.4%
$12.0M
——
Apr 28, 2023Q1 2023
-$1.29Est: -$0.84
-53.6%
-
——
Mar 24, 2023Q4 2022
-$1.04Est: -$0.89
-16.9%
-
——
Oct 28, 2022Q3 2022
-$0.80Est: -$0.95
+15.8%
-
——
Aug 12, 2022Q2 2022
-$0.95Est: -$1.00
+5.0%
-
——
Apr 27, 2022Q1 2022
-$0.95Est: -$0.90
-5.6%
-
——
Mar 25, 2022Q4 2021
-$0.80Est: -$0.70
-14.3%
-
——
Oct 26, 2021Q3 2021
-$0.60Est: -$0.65
+7.7%
-
——
Aug 6, 2021Q2 2021
-$0.40Est: -$0.55
+27.3%
-
——
View all filings on SEC EDGAR

Cookie Preferences

We use cookies for analytics. See our Privacy and Cookie Policy.